HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Stent Graft Helps Keep Vascular Access Clear

By HospiMedica International staff writers
Posted on 03 Dec 2014
Print article
Image: The Fluency Plus endovascular stent graft (Photo courtesy of BARD Peripheral Vascular).
Image: The Fluency Plus endovascular stent graft (Photo courtesy of BARD Peripheral Vascular).
Using a stent graft may improve vascular access patency in dialysis patients who suffered stenosis in an original venous stent, according to a new study.

Researchers at the University of Wisconsin (Madison, USA) enrolled 265 patients from 23 US sites who had in-stent restenotic lesions in the venous outflow of their vascular access, and randomized them to angioplasty alone, or angioplasty plus the the Fluency Plus endovascular stent graft, which can open blockages in previously placed stents on the venous side of the dialysis access circuit. The primary endpoints were superiority of access circuit primary patency through six months and safety through 30 days, and a secondary endpoint was postintervention lesion patency.

The results showed that the rates of access circuit primary patency were better over six months among patients who had a flexible stent graft placed inside the stenosed stent (16.7%) compared to those who did not (3%). Postintervention lesion patency was higher in the stent graft group (65.2% versus 10.4%, respectively), and remained true for patients whether they had an arteriovenous (AV) graft or a fistula. Freedom from binary restenosis at 90 days was also markedly higher in the stent graft group (81% versus 25%). The study was presented at Kidney Week, held during November 2014, in Philadelphia (PA, USA).

“We found that the stent graft is far superior to angioplasty alone, which was previously the standard of care,” said lead author and study presenter Alexander Yevzlin, MD. “This should change the first-line therapy for this disease state. It will reduce the frequency with which patients need to be treated for in-stent restenosis.”

The Fluency Plus endovascular stent graft, a product of BARD Peripheral Vascular (Tempe, AZ, USA), is intended for the treatment of in-stent restenotic peripheral and central lesions in patients with AV grafts and fistulae. The flexible metal stent is lined with expanded poly-tetrafluoroethylene (ePTFE), and is available in a broad range of implant diameters and lengths.

Related Links:

University of Wisconsin
BARD Peripheral Vascular


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Ventilator
TRventi-3D

Print article

Channels

Critical Care

view channel
Image: The new risk assessment tool determines patient-specific risks of developing unfavorable outcomes with heart failure (Photo courtesy of 123RF)

Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients

Heart failure is a serious condition where the heart cannot pump sufficient blood to meet the body's needs, leading to symptoms like fatigue, weakness, and swelling in the legs and feet, and it can ultimately... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more